---
$id: https://graph.org.ai/products/commodity/51181538
$type: Product
source: UNSPSC
code: "51181538"
title: "Fidarestat"
class: "51181500"
classTitle: "Antidiabetic agents and hyperglycemic agents"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fidarestat

**UNSPSC Code**: 51181538
**Class**: [Antidiabetic agents and hyperglycemic agents](Antidiabetic agents and hyperglycemic agents.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cyp11b2 gene with the molecular formula C12H10FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8SH8T1164U, chemically known as spiro(4h-1-benzopyran-4,4-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2,5-dioxo-, (2s-cis)- but generally known as fidarestat, which bears US NIH Compound Identifier 160024. European Medicines Agency schedules Fidarestat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07624MIG. The term FIDARESTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). FIDARESTAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fidarestat under HS 29349990 and SITC 51579. As of Q4 2014, FIDARESTAT remains the US FDA Preferred Term for this commodity. Fidarestat bears US NLM identifiers UMLS ID C0905478 and NCI Concept Code C81355. SMILES: C1[C@H](OC2=C([C@]13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N.

